13G Filing: Great Point Partners and Kura Oncology Inc (KURA)

Page 3 of 10

Page 3 of 10 – SEC Filing

CUSIP
No.  50127T109
13G Page
3 of 9 Pages
1.

NAMES OF REPORTING PERSONS

Dr. Jeffrey R. Jay, M.D.

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
(ENTITIES ONLY):

2. CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
3. SEC
USE ONLY
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING PERSON

WITH

5.

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

1,638,461

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

1,638,461

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON

1,638,461

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN
ROW (9) EXCLUDES CERTAIN SHARES
(See Instructions)

o
11.

PERCENT OF CLASS REPRESENTED BY AMOUNT
IN ROW (9)

5.92%2

12.

TYPE OF REPORTING PERSON (See Instructions)

IN

Follow Kura Oncology Inc. (NASDAQ:KURA)

Page 3 of 10